Background: Krüppel-like factor 2 (KLF2) and protease-activated receptor-1 (PAR-1) are 2 novel factors that play important roles in inflammation and coagulation, yet their relationship with vulnerable plaques and statin remains uncertain. The purpose of this study was to explore the expression of KLF2 and PAR-1 in vulnerable plaques of ApoE gene knockout (ApoE(-/-)) mice and the pharmaceutical effect of statin on the expression of KLF2 and PAR-1.

Methods: ApoE(-/-) mice were randomized into an early-treatment group and a late-treatment group. Each group was randomized into 4 subgroups: normal diet control, high-fat diet control, high-dose statin, and low-dose statin. After 8 weeks of intervention with statin, the aortas were harvested to determine KLF2 and PAR-1 expression by semiquantitative reverse transcription-polymerase chain reaction, Western blotting, and immunohistochemical analyses. The relative area of plaque, the ratio of fibrous cap thickness to tunica intima/media thickness, and the vulnerability index of atherosclerotic plaques were calculated to evaluate plaque vulnerability.

Results: KLF2 increased whereas PAR-1 decreased in vulnerable plaques at messenger RNA, protein, and histologic levels. Atorvastatin increased KLF2 and decreased PAR-1 expression.

Conclusions: Plaque vulnerability correlated negatively with KLF2 but positively with PAR-1. Upregulation of KLF2 and downregulation of PAR-1 could be direct or indirect effects of statin therapy.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cjca.2012.11.012DOI Listing

Publication Analysis

Top Keywords

vulnerable plaques
16
apoe-/- mice
12
krüppel-like factor
8
protease-activated receptor-1
8
intervention statin
8
klf2
8
expression klf2
8
klf2 par-1
8
diet control
8
statin
7

Similar Publications

Objective: Recent studies suggested that the medical control of atherogenic lipoproteins is not sufficient for stroke prevention. A low apolipoprotein A-I (apoA-I) level may play a crucial role in the anti-atherogenic effects of high-density lipoprotein (HDL-C) and may also be associated with symptomatic vulnerable plaques in carotid artery stenosis. Therefore, the present study investigated the relationship between apoA-I levels and the status of carotid artery stenosis.

View Article and Find Full Text PDF

Differentiation of Atherosclerotic Carotid Plaque Components With Dual-Energy Computed Tomography.

Invest Radiol

January 2025

From the Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, Maastricht, the Netherlands (M.A., J.B., T.F., A.A.P., M.E.K.); CARIM, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, the Netherlands (M.A., J.B., M.J.J.G., W.H.M., R.J.v.O., M.E.K.); Department of Pathology, Maastricht University Medical Center, Maastricht, the Netherlands (M.J.J.G.); Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences: Atherosclerosis & Ischemic Syndrome; Amsterdam Infection and Immunity: Inflammatory Diseases; Amsterdam UMC Location University of Amsterdam, Amsterdam, the Netherlands (M.J.J.G.); Department of Neurology, Zuyderland Medical Center, Heerlen, the Netherlands (T.H.C.M.L.S.); Department of Neurology, Zuyderland Medical Center, Sittard, the Netherlands (N.P.v.O.); Department of Vascular Surgery, Maastricht University Medical Center, Maastricht, the Netherlands (J.-W.H.C.D.); Department of Clinical Neurophysiology, Maastricht University Medical Center, Maastricht, the Netherlands (W.H.M.); Department of Neurology, Maastricht University Medical Center, Maastricht, the Netherlands (R.J.v.O.); and School for Mental Health and Neuroscience (MHeNs), Maastricht University, Maastricht, the Netherlands (A.A.P.).

Objectives: Carotid plaque vulnerability is a strong predictor of recurrent ipsilateral stroke, but differentiation of plaque components using conventional computed tomography (CT) is suboptimal. The aim of our study was to evaluate the ability of dual-energy CT (DECT) to characterize atherosclerotic carotid plaque components based on the effective atomic number and effective electron density using magnetic resonance imaging (MRI) and, where possible, histology as the reference standard.

Materials And Methods: Patients with recent cerebral ischemia and a ≥2-mm carotid plaque underwent computed tomography angiography and MRI.

View Article and Find Full Text PDF

In Situ Conversion of Atherosclerotic Plaques' Iron into Nanotheranostics.

J Am Chem Soc

January 2025

Materdicine Lab, School of Life Sciences, Shanghai University, 200444 Shanghai, P. R. China.

The presence of a substantial necrotic core in atherosclerotic plaques markedly heightens the risk of rupture, a consequence of elevated iron levels that exacerbate oxidative stress and lipid peroxidation, thereby sustaining a detrimental cycle of ferroptosis and inflammation. Concurrently targeting both ferroptosis and inflammation is crucial for the effective treatment of vulnerable plaques. In this study, we introduce gallium hexacyanoferrate nanoabsorption catalysts (GaHCF NACs) designed to disrupt this pathological cycle.

View Article and Find Full Text PDF

Ischemic stroke (IS), a cerebrovascular condition, is commonly detected by evaluating carotid intima-media (CIA) stenosis. Symptomatic CIA stenosis carries a high risk (up to 32%) of another ischemic event within 12 weeks, while asymptomatic CIA stenosis has an annual risk ranging from 1% to 2%. Therefore, this study aims to explore the diagnostic value of clinical features and carotid plaque characteristics in both symptomatic and asymptomatic IS.

View Article and Find Full Text PDF

Advances in the Application of Artificial Intelligence in the Ultrasound Diagnosis of Vulnerable Carotid Atherosclerotic Plaque.

Ultrasound Med Biol

January 2025

Department of Ultrasound, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China; Departments of Medical Imaging, Quanzhou Medical College, Quanzhou, China. Electronic address:

Vulnerable atherosclerotic plaque is a type of plaque that poses a significant risk of high mortality in patients with cardiovascular disease. Ultrasound has long been used for carotid atherosclerosis screening and plaque assessment due to its safety, low cost and non-invasive nature. However, conventional ultrasound techniques have limitations such as subjectivity, operator dependence, and low inter-observer agreement, leading to inconsistent and possibly inaccurate diagnoses.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!